Search research articles
Contact Us
Filters
Showing results (81-90 of 159) with videos related to
Page
of 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2011
Common cancer stem cell gene variants predict colon cancer recurrence
Armin Gerger, Wu Zhang, Dongyun Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 4, 2014
A let-7 microRNA-binding site polymorphism in KRAS predicts improved outcome in patients with metastatic colorectal cancer treated with salvage cetuximab/panitumumab monotherapy
Zenia Saridaki, Joanne B Weidhaas, Heinz-Josef Lenz, et al.
Cancers
|
July 8, 2020
Single Nucleotide Polymorphisms in MiRNA Binding Sites of Nucleotide Excision Repair-Related Genes Predict Clinical Benefit of Oxaliplatin in FOLFOXIRI Plus Bevacizumab: Analysis of the TRIBE Trial
Mitsukuni Suenaga, Marta Schirripa, Shu Cao, et al.
American Journal of Hematology
|
January 3, 2023
Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus-specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis
Corinna La Rosa, Ibrahim Aldoss, Yoonsuh Park, et al.
Pharmacogenetics and Genomics
|
January 15, 2008
Thymidylate synthase haplotype is associated with tumor recurrence in stage II and stage III colon cancer
Georg Lurje, Wu Zhang, Dongyun Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 28, 2011
Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer
Armin Gerger, Anthony El-Khoueiry, Wu Zhang, et al.
Journal of the National Cancer Institute
|
February 26, 2015
Primary tumor location as a prognostic factor in metastatic colorectal cancer
Fotios Loupakis, Dongyun Yang, Linda Yau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 2008
Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia
Agustin A Garcia, Hal Hirte, Gini Fleming, et al.
Transplantation and Cellular Therapy
|
November 29, 2021
Cytokine Release Syndrome Following Peripheral Blood Stem Cell Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide
Salman Otoukesh, Hany Elmariah, Dongyun Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2008
Polymorphisms in cyclooxygenase-2 and epidermal growth factor receptor are associated with progression-free survival independent of K-ras in metastatic colorectal cancer patients treated with single-agent cetuximab
Georg Lurje, Fumio Nagashima, Wu Zhang, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 159) with videos related to
Sort By:
Page
of 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2011
Common cancer stem cell gene variants predict colon cancer recurrence
Armin Gerger, Wu Zhang, Dongyun Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 4, 2014
A let-7 microRNA-binding site polymorphism in KRAS predicts improved outcome in patients with metastatic colorectal cancer treated with salvage cetuximab/panitumumab monotherapy
Zenia Saridaki, Joanne B Weidhaas, Heinz-Josef Lenz, et al.
Cancers
|
July 8, 2020
Single Nucleotide Polymorphisms in MiRNA Binding Sites of Nucleotide Excision Repair-Related Genes Predict Clinical Benefit of Oxaliplatin in FOLFOXIRI Plus Bevacizumab: Analysis of the TRIBE Trial
Mitsukuni Suenaga, Marta Schirripa, Shu Cao, et al.
American Journal of Hematology
|
January 3, 2023
Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus-specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis
Corinna La Rosa, Ibrahim Aldoss, Yoonsuh Park, et al.
Pharmacogenetics and Genomics
|
January 15, 2008
Thymidylate synthase haplotype is associated with tumor recurrence in stage II and stage III colon cancer
Georg Lurje, Wu Zhang, Dongyun Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 28, 2011
Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer
Armin Gerger, Anthony El-Khoueiry, Wu Zhang, et al.
Journal of the National Cancer Institute
|
February 26, 2015
Primary tumor location as a prognostic factor in metastatic colorectal cancer
Fotios Loupakis, Dongyun Yang, Linda Yau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 2008
Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia
Agustin A Garcia, Hal Hirte, Gini Fleming, et al.
Transplantation and Cellular Therapy
|
November 29, 2021
Cytokine Release Syndrome Following Peripheral Blood Stem Cell Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide
Salman Otoukesh, Hany Elmariah, Dongyun Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2008
Polymorphisms in cyclooxygenase-2 and epidermal growth factor receptor are associated with progression-free survival independent of K-ras in metastatic colorectal cancer patients treated with single-agent cetuximab
Georg Lurje, Fumio Nagashima, Wu Zhang, et al.
Page
of 16